TimesSquare Capital Management LLC lessened its holdings in shares of New Frontier Health Co. (NYSE:NFH) by 18.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 48,800 shares of the company’s stock after selling 11,200 shares during the period. TimesSquare Capital Management LLC owned 0.17% of New Frontier Health worth $551,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Squarepoint Ops LLC bought a new stake in shares of New Frontier Health during the 4th quarter valued at $125,000. Verition Fund Management LLC boosted its holdings in shares of New Frontier Health by 13.0% during the 4th quarter. Verition Fund Management LLC now owns 43,476 shares of the company’s stock valued at $374,000 after buying an additional 5,000 shares in the last quarter. Prelude Capital Management LLC raised its position in shares of New Frontier Health by 279.9% in the 4th quarter. Prelude Capital Management LLC now owns 73,970 shares of the company’s stock worth $636,000 after purchasing an additional 54,500 shares during the last quarter. Renaissance Technologies LLC raised its position in shares of New Frontier Health by 158.8% in the 4th quarter. Renaissance Technologies LLC now owns 194,600 shares of the company’s stock worth $1,674,000 after purchasing an additional 119,400 shares during the last quarter. Finally, Morgan Stanley raised its position in shares of New Frontier Health by 3.4% in the 4th quarter. Morgan Stanley now owns 4,173,588 shares of the company’s stock worth $35,893,000 after purchasing an additional 137,334 shares during the last quarter.
NFH opened at $11.39 on Friday. New Frontier Health Co. has a 1 year low of $7.30 and a 1 year high of $11.60. The stock has a 50-day moving average of $11.22. The company has a current ratio of 1.05, a quick ratio of 0.95 and a debt-to-equity ratio of 0.26. The stock has a market cap of $327.46 million, a price-to-earnings ratio of -26.49 and a beta of 0.11.
Separately, Credit Suisse Group reaffirmed a “neutral” rating and issued a $12.00 price target on shares of New Frontier Health in a research report on Thursday, April 15th.
About New Frontier Health
New Frontier Health Corporation provides healthcare services. It operates a network of hospital inpatient departments and integrated outpatient clinics, including satellite feeder clinics. The company's facilities include 24/7 emergency rooms, intensive care units, neonatal intensive care units, operating rooms, clinical laboratories, radiology, and blood banking services.
Recommended Story: Current Ratio
Want to see what other hedge funds are holding NFH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for New Frontier Health Co. (NYSE:NFH).
Receive News & Ratings for New Frontier Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for New Frontier Health and related companies with MarketBeat.com's FREE daily email newsletter.